State Street’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.9M Buy
1,384,018
+37,693
+3% +$1.53M ﹤0.01% 1749
2025
Q4
$54.7M Buy
1,346,325
+83,694
+7% +$3.64M ﹤0.01% 1692
2025
Q3
$59.6M Sell
1,262,631
-30,080
-2% -$1.56M ﹤0.01% 1636
2025
Q2
$67.6M Sell
1,292,711
-8,828
-0.7% -$484K ﹤0.01% 1523
2025
Q1
$78.9M Sell
1,301,539
-56,919
-4% -$3.67M ﹤0.01% 1395
2024
Q4
$93.2M Buy
1,358,458
+51,212
+4% +$3.57M ﹤0.01% 1380
2024
Q3
$94.3M Buy
1,307,246
+54,899
+4% +$3.87M ﹤0.01% 1358
2024
Q2
$87.1M Buy
1,252,347
+37,272
+3% +$2.72M ﹤0.01% 1353
2024
Q1
$97.5M Buy
1,215,075
+28,022
+2% +$2.5M ﹤0.01% 1322
2023
Q4
$130M Buy
1,187,053
+8,342
+0.7% +$863K 0.01% 1126
2023
Q3
$119M Buy
1,178,711
+7,467
+0.6% +$858K 0.01% 1071
2023
Q2
$159M Buy
1,171,244
+6,109
+0.5% +$746K 0.01% 924
2023
Q1
$121M Buy
1,165,135
+33,781
+3% +$3.27M 0.01% 1058
2022
Q4
$101M Buy
1,131,354
+53,856
+5% +$4.47M 0.01% 1160
2022
Q3
$86.6M Buy
1,077,498
+30,369
+3% +$2.86M 0.01% 1206
2022
Q2
$100M Buy
1,047,129
+3,737
+0.4% +$448K 0.01% 1146
2022
Q1
$155M Buy
1,043,392
+19,517
+2% +$2.73M 0.01% 1001
2021
Q4
$145M Sell
1,023,875
-8,702
-0.8% -$1.23M 0.01% 1027
2021
Q3
$135M Buy
1,032,577
+18,330
+2% +$2.4M 0.01% 1049
2021
Q2
$140M Buy
1,014,247
+38,633
+4% +$5.29M 0.01% 1058
2021
Q1
$128M Buy
975,614
+3,178
+0.3% +$382K 0.01% 1051
2020
Q4
$109M Buy
972,436
+26,409
+3% +$2.5M 0.01% 1079
2020
Q3
$74.6M Sell
946,027
-36,372
-4% -$2.97M 0.01% 1163
2020
Q2
$70.9M Buy
982,399
+35,013
+4% +$2.44M 0.01% 1206
2020
Q1
$54.4M Buy
947,386
+43,869
+5% +$4.05M ﹤0.01% 1204
2019
Q4
$101M Sell
903,517
-9,249
-1% -$986K 0.01% 1046
2019
Q3
$87.9M Sell
912,766
-104,828
-10% -$9.84M 0.01% 1080
2019
Q2
$87.3M Buy
1,017,594
+19,080
+2% +$1.57M 0.01% 1139
2019
Q1
$83.3M Sell
998,514
-1,005
-0.1% -$73K 0.01% 1127
2018
Q4
$64.4M Sell
999,519
-50,584
-5% -$3.46M 0.01% 1197
2018
Q3
$83.2M Buy
1,050,103
+92,517
+10% +$7.16M 0.01% 1197
2018
Q2
$70.1M Buy
957,586
+202,881
+27% +$13.8M 0.01% 1268
2018
Q1
$47.8M Sell
754,705
-137,761
-15% -$8.22M ﹤0.01% 1454
2017
Q4
$45.5M Buy
892,466
+191,667
+27% +$9.98M ﹤0.01% 1483
2017
Q3
$36.8M Sell
700,799
-259
-0% -$13K ﹤0.01% 1583
2017
Q2
$35.7M Buy
701,058
+22,919
+3% +$1.13M ﹤0.01% 1574
2017
Q1
$30.1M Buy
678,139
+47,143
+7% +$2.03M ﹤0.01% 1648
2016
Q4
$27.9M Buy
630,996
+39,879
+7% +$1.69M ﹤0.01% 1657
2016
Q3
$23.7M Buy
591,117
+29,090
+5% +$1.24M ﹤0.01% 1674
2016
Q2
$26.8M Buy
562,027
+3,712
+0.7% +$157K ﹤0.01% 1546
2016
Q1
$23.4M Sell
558,315
-27,005
-5% -$1.06M ﹤0.01% 1619
2015
Q4
$25.8M Buy
585,320
+16,465
+3% +$715K ﹤0.01% 1532
2015
Q3
$27.2M Sell
568,855
-11,809
-2% -$648K ﹤0.01% 1541
2015
Q2
$33.8M Sell
580,664
-31,910
-5% -$1.72M ﹤0.01% 1504
2015
Q1
$30.9M Sell
612,574
-631
-0.1% -$30.9K ﹤0.01% 1522
2014
Q4
$27.6M Sell
613,205
-1,009
-0.2% -$42.3K ﹤0.01% 1565
2014
Q3
$22.6M Sell
614,214
-17,819
-3% -$707K ﹤0.01% 1649
2014
Q2
$27.9M Sell
632,033
-29,357
-4% -$1.33M ﹤0.01% 1587
2014
Q1
$28.7M Buy
661,390
+2,808
+0.4% +$125K ﹤0.01% 1512
2013
Q4
$28M Sell
658,582
-18,927
-3% -$719K ﹤0.01% 1522
2013
Q3
$23M Sell
677,509
-4,506
-0.7% -$147K ﹤0.01% 1606
2013
Q2
$21.3M Buy
+682,015
New +$22.1M ﹤0.01% 1595

Other funds holding CNMD

State Street's CNMD Position: Q1 2026 in Review

State Street increased its CONMED (CNMD) stake by 2.8% in Q1 2026, buying an estimated $1.53M and bringing the position to 1,384,018 shares worth $48.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1749.

State Street first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $159M in Q2 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • State Street held 1,384,018 shares of CONMED worth $48.9M as of Q1 2026.
  • State Street bought 37,693 CONMED shares in Q1 2026, an estimated $1.53M.
  • CONMED made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1749 holding.
  • State Street first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
  • State Street's CONMED position peaked at $159M in Q2 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.